Plenary Session:
8. Opening Plenary
Wednesday, October 3, 2018: 3:45 PM-5:15 PM
Room: N Hall D

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss research in space and the impact on potential advancements to patient care here on Earth
  • explain possible consequences for disease transmission between Earth and space, and the protocols for infection prevention and control utilized

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Transplant ID, Trainee, Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID


Moderator:  Inger Damon, MD, PhD, FIDSA, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases

Presentations:
3:45 PM
23
Opening Plenary Presentation
Kate Rubins, PhD

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-367-L04-P

Disclosures:

I. Damon, None

See more of: Plenary Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.